AIM ImmunoTech (AIM)
0.23
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 8-K AIM ImmunoTech Inc. For: Aug 31
September 4, 2026 4:06 PM - SEC Filing
Frontier AI models score worse than a coin flip on grammar in some languages, according to TrainAI
August 25, 2026 8:00 AM - PR NewsWire
Form 8-K AIM ImmunoTech Inc. For: Aug 11
August 11, 2026 8:40 AM - SEC Filing
Form 8-K AIM ImmunoTech Inc. For: Aug 07
August 10, 2026 8:41 AM - SEC Filing
Form 10-Q AIM ImmunoTech Inc. For: Jun 30
August 7, 2026 4:36 PM - SEC Filing
Form 8-K AIM ImmunoTech Inc. For: Jul 31
August 6, 2026 5:23 PM - SEC Filing
Form 8-K AIM ImmunoTech Inc. For: Jul 31
August 5, 2026 8:00 AM - SEC Filing
Form 8-K AIM ImmunoTech Inc. For: Jul 15
July 16, 2026 4:06 PM - SEC Filing
Form S-8 AIM ImmunoTech Inc.
July 9, 2026 4:06 PM - SEC Filing
AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program
July 7, 2026 9:03 AM - Globe NewsWire
Form DEF 14A AIM ImmunoTech Inc. For: Jun 25
June 25, 2026 8:55 AM - SEC Filing
Form 424B3 AIM ImmunoTech Inc.
June 24, 2026 4:31 PM - SEC Filing
AIM ImmunoTech completes DURIPANC enrollment, eyes 2027 data
June 24, 2026 8:30 AM - StreetInsider
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
June 24, 2026 8:29 AM - Globe NewsWire
Form EFFECT AIM ImmunoTech Inc.
June 24, 2026 6:03 AM - SEC Filing
Form 424B3 AIM ImmunoTech Inc.
June 18, 2026 4:06 PM - SEC Filing
AIM ImmunoTech (AIM) files for 13.08M share offering by selling stockholders
June 18, 2026 8:06 AM - StreetInsider
Form S-1 AIM ImmunoTech Inc.
June 18, 2026 8:01 AM - SEC Filing
Form EFFECT AIM ImmunoTech Inc.
June 17, 2026 6:03 AM - SEC Filing
Form PRE 14A AIM ImmunoTech Inc. For: Jun 15
June 15, 2026 5:26 PM - SEC Filing
Form 8-K AIM ImmunoTech Inc. For: Jun 12
June 15, 2026 8:01 AM - SEC Filing
Form 8-K AIM ImmunoTech Inc. For: Jun 09
June 11, 2026 4:16 PM - SEC Filing
Form 8-K AIM ImmunoTech Inc. For: Jun 09
June 10, 2026 4:59 PM - SEC Filing
Form 424B5 AIM ImmunoTech Inc.
June 10, 2026 2:01 PM - SEC Filing
AIM ImmunoTech raises $2.65 million in registered direct offering
June 9, 2026 9:30 AM - StreetInsider
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules
June 9, 2026 9:30 AM - Globe NewsWire
AIM ImmunoTech (AIM) Halted, News Pending
June 9, 2026 9:27 AM - StreetInsider
AIM ImmunoTech (AIM) files for 31.3M share offering by selling stockholders
June 8, 2026 4:08 PM - StreetInsider
Form S-1 AIM ImmunoTech Inc.
June 8, 2026 4:06 PM - SEC Filing
AIM ImmunoTech reports progress in pancreatic cancer drug trial
June 8, 2026 8:34 AM - StreetInsider
Full Article List
